Development and Preliminary Dosimetric Evaluation of a 3D-Printed Custom Tissue Compensator for Head and Neck Cancer Radiotherapy: A Proof-of-Concept Case Series
Technology in Cancer Research & Treatment · 2026-08 · 25
DOI: 10.1177/15330338261478186 ↗Kurz gefasst
Fachartikel in der Zeitschrift Technology in Cancer Research & Treatment, online erschienen am 13.08.2026. Verfasst von Chuxiang Jian und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai, China. Hauptthemen laut MEDLINE: Head and Neck Neoplasms, Printing, Three-Dimensional, Radiotherapy Planning, Computer-Assisted. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Xiamen Health Commission High-Quality Development S&T Talent Nurturing Program.
Abstract (Originalsprache)
Introduction
Achieving an optimal therapeutic ratio in head and neck cancer (HNC) radiotherapy requires balancing dose conformity with organ-at-risk (OAR) sparing. Traditional auxiliary devices often lack the customized geometry needed for modern techniques. This study developed and evaluated a 3D-printed integrated tissue compensator that serves as both a positioning stent for OAR displacement and a conformal bolus for dose build-up.
Methods
In this case series, five HNC patients (including floor of mouth, tongue, and nasal cavity and sinus cancers) were prospectively and consecutively enrolled, and their computed tomography (CT) data were used to fabricate the compensators. Dosimetric comparisons were conducted between the 3D-printed compensator, a simulated air cavity, and a conventional bite block.
Results
The integrated device demonstrated adequate geometric fidelity, maintaining random translational setup errors (σ) at ≤ 1.34 mm, comparable to traditional immobilization. Compared to the conventional group, the device demonstrated a numerical reduction in the maximum dose to the hard palate and the mean dose to the external surface, while ensuring effective dose build-up in the target region. Compared with the air cavity group, the observed numerical reductions in dose for key OARs (oral cavity, mandible, and parotid gland) approached but did not reach conventional statistical significance (p = 0.063). Furthermore, the device maintained comparable conformity (CI) and homogeneity (HI) indices, showing an observed numerical improvement in homogeneity for high-dose targets.
Conclusion
This feasibility study demonstrates that a 3D-printed integrated tissue compensator offers potential dosimetric advantages over conventional approaches. By maintaining setup reproducibility and OAR sparing, this device represents a practical exploratory tool for HNC radiotherapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai, China.
- Department of Radiation Oncology, Xiamen Cancer Hospital, Xiamen, Fujian, China.
ORCID-Profile: Chuxiang Jian, Qian Wu
Förderung
- Xiamen Health Commission High-Quality Development S&T Talent Nurturing Program
Zitieren
APA
Jian, C., Xia, X., Wang, J., Lian, C., Cao, X., Zhou, P., Xu, D., Wu, Q., & Du, C. (2026). Development and Preliminary Dosimetric Evaluation of a 3D-Printed Custom Tissue Compensator for Head and Neck Cancer Radiotherapy: A Proof-of-Concept Case Series. Technology in Cancer Research & Treatment, 25. https://doi.org/10.1177/15330338261478186
Vancouver
Jian C, Xia X, Wang J, Lian C, Cao X, Zhou P, et al. Development and Preliminary Dosimetric Evaluation of a 3D-Printed Custom Tissue Compensator for Head and Neck Cancer Radiotherapy: A Proof-of-Concept Case Series. Technology in Cancer Research & Treatment. 2026;25. doi:10.1177/15330338261478186
BibTeX
@article{Jian2026,
author = {Jian, Chuxiang and Xia, Xiang and Wang, Jiazhou and Lian, Chenlu and Cao, Xuexue and Zhou, Ping and Xu, Dayu and Wu, Qian and Du, Chengrun},
title = {Development and Preliminary Dosimetric Evaluation of a 3D-Printed Custom Tissue Compensator for Head and Neck Cancer Radiotherapy: A Proof-of-Concept Case Series},
journal = {Technology in Cancer Research & Treatment},
year = {2026},
volume = {25},
doi = {10.1177/15330338261478186}
}
EUVIMED